Clinical Trial Update: Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating early initiation of evolocumab on lipid profiles in patients with acute coronary syndrome undergoing percutaneous coronary intervention…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Hyperlipidemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Yonsei University | Conditions: Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Phase 4 | Status: COMPLETED